Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Salarius Pharmaceuticals Inc
(NQ:
SLRX
)
0.4170
UNCHANGED
Streaming Delayed Price
Updated: 3:53 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Salarius Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 24, 2021
Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 21, 2021
Gainers Sio Gene Therapies (NASDAQ:SIOX) ...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 14, 2021
Gainers Evaxion Biotech (NASDAQ:EVAX) sha...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 12, 2021
Gainers Celyad Oncology (NASDAQ:CYAD) sto...
Via
Benzinga
Salarius Pharmaceuticals: Q1 Earnings Insights
May 12, 2021
Shares of Salarius Pharmaceuticals (NASDAQ:SLRX) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 72.73% year over...
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For May 12, 2021
May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 13, 2021
Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.